Windtree Therapeutics Inc (WINT)

$0.14 +0.03 (24.55%)
Market Cap 1.77M
Revenue (ttm) 0.00
Net Income (ttm) -1.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.05
Volume 6,696,000
Avg Vol 12,863,387
Day's Range N/A - N/A
Shares Out 3.66M
Stochastic %K 10%
Beta 0.63
Analysts Strong Buy
Price Target $4.00

Company Profile

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infan...

Industry: Biotechnology
Sector: Healthcare
Phone: 215 488 9300
Address:
2600 Kelly Road, Suite 100, Warrington, United States
DJORCKO
DJORCKO Apr. 7 at 2:04 PM
$WINT average from 1.23 to 0.14 now , 187k shares. Down heavily but still believe
0 · Reply
1nvestorGadget
1nvestorGadget Apr. 7 at 1:38 PM
$WINT How are these people still smiling and not in prison?
1 · Reply
BioTechHealthX
BioTechHealthX Apr. 5 at 5:34 PM
$WINT Windtree Therapeutics Inc. (NASDAQ:WINT) is back on speculative investors’ radar as it explores strategic alternatives and partnerships. With multiple catalysts potentially brewing, this biotech turnaround story could deliver surprising upside. https://biotechhealthx.com/biotech-news/is-it-still-a-great-move-to-invest-in-windtree-therapeutics-wint/
0 · Reply
BioTechHealthX
BioTechHealthX Apr. 2 at 8:59 AM
$CVM $KOD $SGMO $VSA $WINT These top 5 biotech stocks combine strong catalysts, clinical progress, and growth potential. Find out which companies could deliver massive returns. https://biotechhealthx.com/biotech-news/top-5-biotech-stocks-that-could-deliver-1000-returns/
1 · Reply
BioTechHealthX
BioTechHealthX Apr. 2 at 8:28 AM
$CVM $KOD $TBPH $VSA $WINT From high-risk moonshots to late-stage clinical winners, these top 5 biotech stocks are capturing massive investor attention. Discover which companies are nearing breakthroughs, regulatory catalysts, and explosive upside potential before the crowd catches on. https://biotechhealthx.com/biotech-news/top-5-biotech-stocks-to-watch-now/
0 · Reply
Dasheldon
Dasheldon Mar. 25 at 8:58 AM
$WINT the merger is close commloan and windtree are going to make huge news
0 · Reply
CrimsonKnight
CrimsonKnight Mar. 25 at 3:32 AM
$WINT
0 · Reply
Lord_Andrew_London
Lord_Andrew_London Mar. 24 at 5:52 PM
$WINT
0 · Reply
sam2680
sam2680 Mar. 24 at 5:40 PM
$WINT RIP all but dead.
0 · Reply
Danaconda1992
Danaconda1992 Mar. 17 at 4:11 PM
$WINT $5 inbound
0 · Reply
Latest News on WINT
No data available.
DJORCKO
DJORCKO Apr. 7 at 2:04 PM
$WINT average from 1.23 to 0.14 now , 187k shares. Down heavily but still believe
0 · Reply
1nvestorGadget
1nvestorGadget Apr. 7 at 1:38 PM
$WINT How are these people still smiling and not in prison?
1 · Reply
BioTechHealthX
BioTechHealthX Apr. 5 at 5:34 PM
$WINT Windtree Therapeutics Inc. (NASDAQ:WINT) is back on speculative investors’ radar as it explores strategic alternatives and partnerships. With multiple catalysts potentially brewing, this biotech turnaround story could deliver surprising upside. https://biotechhealthx.com/biotech-news/is-it-still-a-great-move-to-invest-in-windtree-therapeutics-wint/
0 · Reply
BioTechHealthX
BioTechHealthX Apr. 2 at 8:59 AM
$CVM $KOD $SGMO $VSA $WINT These top 5 biotech stocks combine strong catalysts, clinical progress, and growth potential. Find out which companies could deliver massive returns. https://biotechhealthx.com/biotech-news/top-5-biotech-stocks-that-could-deliver-1000-returns/
1 · Reply
BioTechHealthX
BioTechHealthX Apr. 2 at 8:28 AM
$CVM $KOD $TBPH $VSA $WINT From high-risk moonshots to late-stage clinical winners, these top 5 biotech stocks are capturing massive investor attention. Discover which companies are nearing breakthroughs, regulatory catalysts, and explosive upside potential before the crowd catches on. https://biotechhealthx.com/biotech-news/top-5-biotech-stocks-to-watch-now/
0 · Reply
Dasheldon
Dasheldon Mar. 25 at 8:58 AM
$WINT the merger is close commloan and windtree are going to make huge news
0 · Reply
CrimsonKnight
CrimsonKnight Mar. 25 at 3:32 AM
$WINT
0 · Reply
Lord_Andrew_London
Lord_Andrew_London Mar. 24 at 5:52 PM
$WINT
0 · Reply
sam2680
sam2680 Mar. 24 at 5:40 PM
$WINT RIP all but dead.
0 · Reply
Danaconda1992
Danaconda1992 Mar. 17 at 4:11 PM
$WINT $5 inbound
0 · Reply
Danaconda1992
Danaconda1992 Mar. 17 at 4:06 PM
$WINT
0 · Reply
payitforwardx2
payitforwardx2 Mar. 17 at 3:45 PM
$WINT
0 · Reply
Shroomm
Shroomm Mar. 11 at 7:04 PM
$WINT Volume needs to inflow fast here
0 · Reply
WaveRider666
WaveRider666 Mar. 9 at 10:41 PM
$WINT - During Jed Latkin's leadership tenures, the stock prices of his associated companies have generally experienced significant declines, though the extent varies by firm. Navidea Biopharmaceuticals (CEO/CFO/COO, 2016–2021): The stock price experienced a steep downward trajectory during his five-year tenure. In early 2016, the stock traded around $22.60; by his resignation in October 2021, it had fallen to approximately $1.82, a decline of over 90%. ProPhase Labs (COO/Finance Head, Jan 2023 – Feb 2025): The stock value saw continuous annual declines during this period. The price fell -52.77% in 2023 and -83.62% in 2024. By the time he departed in February 2025, the market capitalization had shrunk from over $81 million (Dec 2023) to roughly $8 million. Windtree Therapeutics (CEO, Dec 2024 – Present): Windtree has faced extreme volatility and a precipitous drop in value. The stock plummeted by -99.99%....
1 · Reply
WaveRider666
WaveRider666 Mar. 9 at 10:36 PM
$WINT - IF you want to be a complete failure and still get paid large sums of money..... just become a CEO, like $WINT CEO Jed Latkin. Every company Jed has been involved with, he has f*cked up completely, but he's still making big bucks as a CEO. Jed is an example of why this world needs thousands of "Luigi's".
2 · Reply
DrMakki
DrMakki Feb. 6 at 2:17 PM
$WINT ??
1 · Reply
WaveRider666
WaveRider666 Jan. 27 at 3:22 PM
$WINT - Toxic dilution scam. This corporation has been in business for more than 25 years and has produced NOTHING other than toxic diluted shares to dump onto the market.
0 · Reply
StocktwitsAragorn
StocktwitsAragorn Jan. 26 at 6:07 PM
$WINT https://www.stockscores.com/charts/charts/?ticker=wint This has been delisted to the pink sheets there is no need to reverse split, it will just trade lower and WINT will continue to sell shares as it moves lower!
1 · Reply
WaveRider666
WaveRider666 Jan. 22 at 8:42 PM
$WINT - There is no bottom. When's the R/S ???
0 · Reply
WaveRider666
WaveRider666 Jan. 13 at 4:03 PM
$WINT - When's the R/S ???? How low are they going to let pps go, before they do the "approved" R/S ???? I'm guessing around $0.01
0 · Reply